Sodium glucose co-transport 2 inhibitors for gout treatment

Hyperuricemia remains the most prevalent cause of gout. Gout patients present with joint inflammation and uric acid crystals deposition manifesting as tophi. The association of gout with increased risk of insulin resistance, diabetes, metabolic disorders, increased cardiometabolic risk, and kidney d...

Descripción completa

Detalles Bibliográficos
Autores principales: Somagutta, Manoj Kumar Reddy, Luvsannyam, Enkhmaa, Jain, Molly, Cuddapah, Gaurav Venkat, Pelluru, Sandeep, Mustafa, Nafisa, Nasereldin, Duaa S., Pendyala, Siva K., Jarapala, Nagendrababu, Padamati, Bhavani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Applied Systems srl 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759282/
https://www.ncbi.nlm.nih.gov/pubmed/36540089
http://dx.doi.org/10.15190/d.2022.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759282/
https://www.ncbi.nlm.nih.gov/pubmed/36540089
http://dx.doi.org/10.15190/d.2022.11

Ejemplares similares